| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 223,673 | 215,426 | 228,652 | 253,641 | | Cost of Revenue | 179,782 | 171,147 | 181,225 | 199,617 | | | Gross Profit | 43,891 | 44,279 | 47,427 | 54,024 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 55,464 | 43,751 | 48,078 | 57,205 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,573) | 528 | (651) | (3,181) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (51) | (143) | 259 | 844 | | Earnings Before Interest And Taxes | (11,902) | 106 | (694) | (2,743) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (11,902) | 106 | (694) | (2,743) | | Income Tax Expense | 280 | 50 | 226 | 871 | | Minority Interest | 13 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,028) | 56 | (920) | (3,614) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,169) | 56 | (920) | (3,614) | | Preferred Stock And Other Adjustments | (3) | 3 |
-
|
-
| | | Net Income Applicable To Common Shares | ($12,172) | $59 | ($920) | ($3,614) |
|
0.19% Nasdaq 
Income Statement
